Central Garden & Pet Company filings document formal disclosures for a public consumer-products company with Pet and Garden operations. Recent 8-K reports cover quarterly and fiscal-year results, operating performance releases, material agreements, board and committee appointments, executive compensation matters and the company’s registered common stock and Class A common stock on Nasdaq.
The filing record also includes disclosures on financing arrangements, including a senior secured asset-based revolving credit facility, and governance matters reported under Exchange Act rules. These documents describe how Central finances and oversees a portfolio of pet care, animal health, lawn, garden, pest-control, seed, fertilizer and related branded products.
Central Garden & Pet Company reported higher results for the quarter ended March 28, 2026, with net sales rising to $906.1 million from $833.5 million. Net income attributable to the company increased to $79.4 million, or $1.28 per diluted share, compared with $0.98 a year earlier.
Growth was broad-based, as Pet segment net sales grew 5% to $476.8 million and Garden segment net sales rose 13% to $429.3 million. Gross profit improved to $299.6 million, with gross margin edging up to 33.1%, helped by stronger branded sales and prior-year facility closure costs dropping out.
For the first six months, net sales reached $1.52 billion and net income was $86.3 million, or $1.39 per diluted share. The company closed a $57 million U.S. asset acquisition of Champion USA LLC and later contributed its pet distribution business into a new Phillips-branded venture, receiving cash and a 20% ownership stake while retaining a more focused portfolio.
Central Garden & Pet Company reported record fiscal 2026 second quarter results, with net sales of $906.2 million, up from $833.5 million a year earlier. Gross margin improved to 33.1% and operating income rose to $113.9 million from $93.3 million.
Net income attributable to the company increased to $79.4 million, with diluted EPS of $1.28 versus $0.98. Non-GAAP diluted EPS was $1.29. Adjusted EBITDA reached $139.5 million, compared with $123.3 million. The company reaffirmed its fiscal 2026 non-GAAP diluted EPS outlook of $2.70 or better.
Pet segment net sales grew to $477 million and Garden segment sales to $429 million, both showing higher operating income. Cash and cash equivalents were $653.2 million, total debt was $1.2 billion, and gross leverage was 2.8x, below the 3.0–3.5x target range.
Central Garden & Pet Co reports that Vanguard Capital Management beneficially owned 617,534 shares of common stock, representing 6.39% of the class as shown with an ownership reference date of 03/31/2026. The filing lists 143,998 shares as sole voting power and states these holdings are held on behalf of Vanguard funds and managed accounts.
Central Garden & Pet Co beneficial ownership filing: Vanguard Portfolio Management reports beneficial ownership of 3,502,876 shares of Common Stock, representing 6.87% of the class. The filing shows sole dispositive power over 3,502,876 shares and sole voting power for 78,198 shares.
Central Garden & Pet Co — Vanguard Portfolio Management reports beneficial ownership of 546,993 shares of Common Stock, representing 5.66% of the class as reported with an as-of date of 03/31/2026. The filing notes dispositive power is exercised by Vanguard Portfolio Management LLC and affiliated investment divisions, and that shares include holdings across Vanguard funds and managed accounts.
Central Garden & Pet Company director and chairman William E. Brown reported a bona fide gift of 2,040 shares of Class A Common Stock. The gift was recorded at a price of $0.00 per share and is classified as a disposition for reporting purposes.
After the gift, Brown holds 937,548 Class A shares directly. An additional 374,258 Class A shares are held indirectly by various family Irrevocable Trusts, where Brown and his spouse serve as co‑trustees with shared investment control and disclaim beneficial ownership except to the extent of their pecuniary interest.
Central Garden & Pet Co: The Vanguard Group filed Amendment No. 19 to its Schedule 13G/A regarding Common Stock, reporting 0 shares beneficially owned and 0% of the class. The filing notes an internal realignment effective January 12, 2026 that led certain Vanguard subsidiaries to report separately.
Central Garden & Pet Co Amendment No. 14 to a Schedule 13G/A states that The Vanguard Group reports 0 shares of Common Stock beneficially owned, representing 0% of the class. The filing explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538 that led certain Vanguard subsidiaries to report holdings separately.
The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026, and lists the issuer's principal executive office at 1340 Treat Blvd, Suite 600, Walnut Creek, CA.
Schwichtenberg Kay reported acquisition or exercise transactions in this Form 4 filing.
CENTRAL GARDEN & PET CO director Kay Schwichtenberg received 3,734 shares of Class A Common Stock as a restricted stock award. The shares were granted at no cash cost under the company’s Nonemployee Director Equity Incentive Plan. Following this grant, she directly holds 3,734 Class A shares.
The filing also reports 303 Class A shares held indirectly by the Kay Schwichtenberg Living Trust. She disclaims beneficial ownership of the trust’s common and Class A shares except to the extent of her pecuniary interest in that trust.
Central Garden & Pet Co director Kay Schwichtenberg reports indirect ownership of 303 shares of Class A Common Stock. The shares are held by the Kay Schwichtenberg Living Trust, and she disclaims beneficial ownership except to the extent of her pecuniary interest in the trust.